Skip to main content
Premium Trial:

Request an Annual Quote

Lynx to Provide Gene Expression Services to Pfizer

NEW YORK, Aug. 12 (GenomeWeb News) - Lynx Therapeutics said today that it has struck a deal with Pfizer to study gene expression in cell samples.

 

Under the arrangement, Pfizer will provide samples from normal and diseased patients for analysis by Lynx's Massively Parallel Signature Sequencing technology.

 

Lynx said it stands to receive payments from Pfizer for the genomics services it provides. Additional terms were not disclosed.

 

In 2003, Lynx has signed agreements to use its MPSS technology with Innovative Dairy Products of Australia, the Genome Institute of Singapore in transcriptome studies; Northeastern University to study the Antarctic icefish; the National Institutes on Aging; Millennium Pharmaceuticals; the Livestock Research Institute in Nairobi, Kenya; the Center for Tropical Veterinary Medicine in Edinburgh, Scotland; and the Institute for Systems Biology and IBM.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.